Vandana Singhal

Vandana Singhal has a diverse work experience that spans over several years. Vandana currently holds the position of Associate Director of Clinical Quality Assurance at Mersana Therapeutics, starting in 2022. Prior to this, they worked at Ocugen as an Associate Director of Clinical Quality and as a Manager of Clinical Quality, from 2021 to 2022.

Vandana also has experience working at GSK, where they held various roles including Clinical Trials Monitor from 2020 to 2021, Senior CSA from 2017 to 2020, and CSA from 2016 to 2017.

Before joining GSK, Vandana worked at the National Center for Advancing Translational Sciences (NCATS) as a Clinical Research Coordinator and Clinical Project Manager from 2014 to 2016. Vandana also worked at Harris Corporation/NIH-NCI as a Clinical Data Manager II in 2014.

In addition, Vandana has research experience, having worked at Johns Hopkins School of Medicine as a Senior Research Assistant from 2010 to 2014. Vandana also worked as a Student Worker at the Kennedy Krieger Institute from 2013 to 2014, where they gained experience in data management and data archiving.

Before their research roles, Vandana worked as a Research Professional at Johns Hopkins Bloomberg School of Public Health from 2008 to 2010. Vandana also worked as a Project Assistant at the Institute of Genomics and Integrative Biology (CSIR) from 2005 to 2007.

Overall, Vandana Singhal has a strong background in clinical quality assurance, clinical trials, research coordination, and data management.

Vandana Singhal earned a Bachelor's degree in Biotechnology from MIET in 2005. Vandana later pursued a Master's degree in Bio-Regulatory Affairs at The Johns Hopkins University from 2008 to 2010. Vandana also obtained additional certifications, including GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus) and Biomedical (Biomed) Comprehensive from the CITI Program in 2023 and 2022 respectively. Additionally, they completed certifications in Conflicts of Interest and GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus) in 2022. Vandana obtained a Human Subjects Research Curriculum certification from the Collaborative Institutional Training Initiative in 2013 and a Clinical Research Audit Certification from Barnett International, although the specific month and year for these two certifications are not provided.